Features of the clinical course of gastroenteritis caused by enteropathogenic Escherichia coli with hemolytic-uremic Gasser syndrome
- 28 August 2026
- journal article
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 104 (6) , 471-475
Abstract
Enteropathogenic infection caused by Escherichia coli, complicated by hemolytic uremic syndrome (HUS), is rare in adults and is associated with a high risk of severe complications and mortality. We present a clinical case of a 25-year-old patient with acute gastroenteritis complicated by infectious-toxic shock, disseminated intravascular coagulation syndrome, acute kidney injury with anuria, and hemolytic uremic syndrome. The etiological diagnosis was confi rmed by bacteriological stool culture with isolation of enteropathogenic Escherichia coli; tests for salmonellosis and shigellosis were negative. The patient received intensive therapy, including antibacterial treatment, infusion therapy, renal replacement therapy, and correction of coagulopathy. Against the background of comprehensive treatment, gradual recovery of renal function and regression of multiple organ failure were observed. The patient was discharged in satisfactory condition. This case highlights the importance of early diagnosis of hemolytic uremic syndrome in adult patients with severe gastroenteritis and the timely initiation of intensive pathogenetic therapy.Keywords
This publication has 9 references indexed in Scilit:
- Escherichia coli encoding Shiga toxin subtype Stx2f causing human infections in England, 2015–2022Journal of Medical Microbiology, 2023
- Diagnosis and Treatment for Shiga Toxin-Producing Escherichia coli Associated Hemolytic Uremic SyndromeToxins, 2022
- Genomic Analysis of a Hybrid Enteroaggregative Hemorrhagic Escherichia coli O181:H4 Strain Causing Colitis with Hemolytic-Uremic SyndromeAntibiotics, 2022
- Whole-genome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing Escherichia coli in SwedenVirulence, 2021
- Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care ManagementToxins, 2021
- Hemolytic uremic syndrome caused by Shiga toxin–producing Escherichia coli in children: incidence, risk factors, and clinical outcomePediatric Nephrology, 2020
- Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative ReviewToxins, 2020
- Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic SyndromeMicroorganisms, 2019
- A case of haemolytic uraemic syndrome (HUS) revealed an outbreak of Shiga toxin-2-producing Escherichia coli O26:H11 infection in a nursery, with long-lasting shedders and person-to-person transmission, Italy 2015Journal of Medical Microbiology, 2018